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Introduction
During the early stages of the secretory pathway, soluble ER-
resident proteins must be sorted and retrieved back to the ER 
from the intermediate compartment of cis-Golgi by a coat pro-
tein (COP) I–mediated transport mechanism (Pelham, 1996; 
Ellgaard et al., 1999). To be recognized by this system, soluble 
ER-resident proteins either require a KDEL-like motif at their 
extreme C terminus or must form a complex with other ER-
resident proteins that have this motif or with ER-resident trans-
membrane proteins (Lewis et al., 1990; Semenza et al., 1990). 
Proteins with a KDEL motif interact with a KDEL receptor in 
the intermediate compartment or in the cis-Golgi. This inter-
action is thought to cause a conformational change in the receptor, 
resulting in the sequestration of the complex to vesicles that are 
retrieved back to the ER. Higher pH in the ER results in dissocia-
tion of the KDEL motif from the receptor, with the empty recep-
tor then being recycled.
The receptor in this process was fi  rst identifi  ed in yeast 
as ER retention-defective complementation group (ERD) 2 
(Semenza et al., 1990). This receptor mainly interacts with pro-
teins that have a C-terminal HDEL motif. It was shown later 
that different organisms have homologues of ERD2 receptors. 
Two human KDEL receptors, ERD21 (Lewis and Pelham, 1990) 
and ERD22 (Lewis and Pelham, 1992a), were identifi  ed ex-
perimentally and a third human KDEL receptor, ERD23, ap-
peared in the Swiss-Prot database in 2000. The potential role 
of ERD23 in ER localization of soluble secretory pathway 
proteins has not been reported. Furthermore, to our knowledge, 
any difference in function between ERD21 and 22 has not 
been reported.
It is known that variants of the KDEL motif also work to 
keep proteins ER resident, with 24 possible variants being listed 
as the Prosite motif for the ER localization of soluble proteins 
([KRHQSA]-[DENQ]-E-L; Hulo et al., 2006). However, there 
are several human proteins that are ER located and contain vari-
ants of the KDEL motif that do not fi  t the Prosite motif (Alanen 
et al., 2003b, 2006). Hence, it is possible that other motifs might 
also work as ER-retrieval signals and this information could 
help defi  ne other ER-resident proteins.
In this study we report the Golgi localization of the third 
human KDEL receptor, identify 35 variants of KDEL that do 
not match the current Prosite motif for localization but that re-
sult in effi  cient ER localization, and report a systematic study 
based on bimolecular fl  uorescence complementation (BiFC) to 
examine which of the three human KDEL receptors interacts 
with which KDEL variant. This study reveals that the human 
KDEL receptors have distinct specifi  cities, suggesting different 
human proteins, or subgroupings of proteins, are retrieved with 
different effi  ciencies by different receptors.
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A
C-terminal KDEL-like motif prevents secretion of 
soluble endoplasmic reticulum (ER)–resident pro-
teins. This motif interacts with KDEL receptors 
  localized in the intermediate compartment and Golgi 
apparatus. Such binding triggers retrieval back to the ER 
via a coat protein I–dependent pathway. To date, two hu-
man KDEL receptors have been reported. Here, we report 
the Golgi localization of a third human KDEL receptor. 
Using a reporter construct system from a screen of 152 
variants, we identiﬁ  ed 35 KDEL-like variants that result in 
efﬁ  cient ER localization but do not match the current 
Prosite motif for ER localization ([KRHQSA]-[DENQ]-E-L). 
We cloned 16 human proteins with one of these motifs 
and all were found in the ER. A subsequent screen by 
bimolecular ﬂ  uorescence complementation determined the 
speciﬁ  cities of the three human KDEL receptors. Each KDEL 
receptor has a unique pattern of motifs with which it inter-
acts. This suggests a speciﬁ  city in the retrieval of human 
proteins that contain different KDEL variants.
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Results
Mammalian cells have three KDEL 
receptors
Proteins containing C-terminal KDEL-like motifs are thought 
to be retrieved back to the ER from the intermediate compart-
ment and the cis-Golgi by KDEL receptors (Lewis et al., 1990; 
Semenza et al., 1990). Although yeast have only a single KDEL 
receptor, many multicellular eukaryotes have more than one and 
two human KDEL receptors have been reported to date (Lewis 
and Pelham, 1990, 1992a). There are, however, three human 
KDEL receptors in the Swiss-Prot database, ERD21, 22, and 23 
(Swiss-Prot accession nos. P24390, P33947, and O43731; chromo-
somal locations 19q13.32, 7p22.1, and 22q13.1, respectively). 
These three KDEL receptors show an amino acid sequence 
pairwise identity of 73.0–83.5% (Fig. 1 A). All three are pre-
dicted to have seven transmembrane-spanning regions with 
their N termini in the ER lumen, their C termini in the cyto-
plasm, and no N-terminal cleavable signal sequence. Based on 
Genecard data (Rebhan et al., 1997; http://www.genecards.org/) 
for the receptors, all three appear to be widely expressed in a 
range of human tissues, with ERD21 being generally more highly 
transcribed than ERD22, which in turn is more highly transcribed 
than ERD23 in most tissue types. The similarity in structure 
and widespread tissue expression suggests that ERD23, the un-
characterized human KDEL receptor, may also play a role in 
ER localization of soluble secretory pathway proteins.
To ensure that we were using a cell line in which all three 
receptors were expressed, RT-PCR was used to examine for the 
presence of mRNA. The results (Fig. 1 B) indicated that all three 
receptors were transcribed in HeLa cells. Quantitative real-time 
PCR showed that the ratio of ERD23 to 21 mRNA in HeLa was 
constantly  5%, which was comparable with the relative levels 
in different tissues. In contrast, the ratio of ERD22 to 21 mRNA 
levels was more variable between different preparations of RNA, 
but the ERD22 mRNA levels from HeLa were consistently sig-
nifi  cantly higher than those of ERD21 (Fig. 1 C). To further 
complicate the issue of multiple mammalian KDEL receptors, 
Figure 1.  The three KDEL receptors found in human cells. (A) Alignment of the three human KDEL receptors. Identical amino acids for all three receptors 
are marked in red and the seven transmembrane regions are underlined by a continuous line. The commercial antibody against the human KDEL receptors 
was raised against the cytoplasmic C terminus of ERD21, which is underlined by a dotted line and shows 90% identity between the three receptors. (B) Total 
RNA was isolated from nontransfected HeLa cells. Three RT-PCR products of 178 (2), 190 (3), and 297 bp (4) represent the presence of the mRNA encoding 
for ERD21, 22, and 23 mRNA, respectively. The molecular mass markers (1) are indicated to the left of the agarose gel. (C) Relative quantiﬁ  cation of mRNA 
for the three human receptors from HeLa cells by real-time PCR. The data represents the mean and standard deviation from 27 RT-PCR reactions normalized 
to the level of the mRNA for ERD21. (D) HeLa cells were transfected with the plasmid for ERD23 C-Myc tag, ﬁ  xed, and double stained with antibodies 
against Myc and giantin. The merged image shows good colocalization of ERD23 and giantin. Bar, 10 μm.KDEL RECEPTOR SPECIFICITIES • RAYKHEL ET AL. 1195
there are two alternative transcripts in the databases for human 
ERD23. The second of these (Isoform O43731-2), which has an 
alternative C terminus, has not been experimentally validated. 
Using primers specifi  c for this transcript, we were unable to 
  detect an RT-PCR product using total RNA from HeLa cells. 
In addition to HeLa cells, Cos7 cells were also used in our studies 
because they have been widely used to study human KDEL 
receptors (Lewis and Pelham, 1992b; Townsley et al., 1993); 
however, we were unable to confi  rm that all three receptors are 
expressed in this monkey cell line.
If ERD23 is to act to retrieve proteins with KDEL-like 
motifs to the ER, it must, as per ERD21 and 22, be located in a 
post-ER secretory pathway compartment. The commercially 
available antibody against the human KDEL receptor was raised 
against a peptide representing the cytoplasmic C terminus of 
ERD21, but this sequence is >90% identical between all three 
receptors (Fig. 1 A) and hence the antibody is cross-reactive be-
tween receptors. The more variable regions of the three recep-
tors are limited, but there are potential specifi  c antigenic regions. 
However, despite trying to raise multiple antipeptide antibodies, 
we were unable to generate an antibody that specifi  cally recog-
nized only one receptor. Thus, to confi  rm the subcellular localiza-
tion of ERD23, a tagged receptor was required. Human ERD23 
was cloned from IMAGE clone 3462392, with a Myc tag at 
  either the N or C terminus of the protein. Each variant was then 
transiently transfected into HeLa or Cos7 cells and localized by 
immunofl  uorescence. N- (ER lumen) and C-terminally (cyto-
plasmic)–tagged variants of ERD23 constructs both showed lo-
calization in a compact perinuclear structure (Fig. 1 D), suggesting 
that ERD23 is normally located in the Golgi. This localization 
was confi  rmed by staining the transfected cells against known 
ER and Golgi markers (calreticulin [CRT] and giantin). This 
post-ER localization is consistent with the putative retrieval 
function of ERD23.
Development of localization reporter 
constructs
With reports of ER-localized proteins with KDEL-like motifs 
that do not match the Prosite motif at their C termini, such as 
ERp18 (EDEL; Alanen et al., 2003b) and ERp27 (KVEL; Alanen 
et al., 2006), it is possible that other, as yet unreported KDEL 
variants could result in ER localization. When examining the 
effi  ciency of variants of the KDEL motif in maintaining the ER 
localization of a soluble protein, other variables, such as the rest 
of the protein sequence and hence possible interaction partners, 
should be minimized. To this end, a reporter construct was de-
veloped onto which variants of the KDEL motif could be added 
at the C terminus. Ideally, this reporter construct should be based 
on a secreted human protein that folds in the ER, has not been 
reported to interact with other ER proteins, is structurally stable, 
has no free thiol groups, and has minimal association with 
ER-resident protein-folding catalysts and molecular chaperones, 
i.e., no cis-proline peptide bonds, no disulphide bonds, and no 
N-glycosylation or other posttranslational modifi  cations. Because 
we were unable to fi  nd a human-secreted protein that matched 
these criteria, we started examining other human secretory pathway 
proteins. The construct selected for testing was based around the 
isolated b domain of protein disulphide isomerase (PDI). This 
domain of PDI is thought to play a structural role in this ER-
resident folding catalyst (Ellgaard and Ruddock, 2005). The struc-
ture has been solved (Kemmink et al., 1999) and it meets all of 
the other selection criteria. The test versions of the reporter con-
struct had the N-terminal ER signal sequence of human CRT to 
target it to the ER, a HA tag for immunological detection, the b 
domain of PDI, and either no retention motif or AKDEL added 
to the C terminus (Fig. 2 A).
Immunofl  uorescence analysis of the test reporter con-
structs transiently transfected into HeLa or Cos7 cells predomi-
nantly showed localization of the AKDEL-containing construct 
in a fi  ne reticular network and the nuclear envelope (Fig. 2 B), 
suggesting that the fusion protein localizes mainly in the ER. 
In contrast, the construct with no C-terminal retention motif 
predominantly showed localization in a compact perinuclear 
structure (Fig. 2 D), suggesting that it is not retained in the ER 
and hence is observed in the Golgi en route to being secreted. 
These localizations were confi  rmed by staining the transfected 
cells against known ER and Golgi markers (CRT and giantin). 
Figure 2.  The reporter construct used to determine the efﬁ  ciency of ER 
  localization based on KDEL motifs. (A) Schematic diagram of construct 
used. The reporter contains the b domain of PDI marked in blue, a HA tag 
marked in green, the signal sequence from CRT marked in yellow, and an 
ER-retention motif added to the C terminus. The reporter with the AKDEL-
retention motif was used as a positive control and the reporter without a 
motif as a negative control. (B–E) HeLa cells were transfected with the plas-
mid for the HA-tagged reporter with the AKDEL motif added (B and C) or 
without the motif (D and E), ﬁ  xed, and double stained with the antibodies 
against the HA tag and CRT (B and E) or giantin (C and D). Merged im-
ages show good colocalization of the reporter with the AKDEL motif with 
the ER marker (B) and the construct with no motif with the Golgi marker (D). 
Bars, 10 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1196
The cellular retention of the AKDEL construct and secretion of 
the construct with no retention motif was subsequently con-
fi  rmed by Western blotting (see KDEL variants found...). These 
results imply that the reporter construct selected was suitable to 
be used and is retained in the ER only via KDEL and not via 
interactions with other ER-resident proteins.
Systematic examination of retention 
variants
To systematically examine the role of each position in the KDEL 
motif in ER localization, all 77 variants of AXDEL, AKXEL, 
AKDXL, and AKDEX (where X is any amino acid) were made 
on the reporter construct.
Figure 3. Immunoﬂ  uorescence-based localization of the reporter constructs. For each construct, transient transfection of HeLa cells was performed in at 
least two independent experiments and the subcellular localization of the reporter construct was determined by examining at least 150 cells costained 
with a CRT antibody (ER marker) and a giantin antibody (Golgi marker). For each transfection, KDEL and no-motif controls were performed in parallel. 
Cells showing abnormal cell morphology or undergoing nuclear division were not included in the analysis. (A–F) The black bar represents the percentage 
of cells with ER-only localization, the gray bar the cells with mixed ER–Golgi localization, and the white bar the cells with Golgi-only localization. 
A, XDEL motifs; B, KXEL motifs; C, KDXL motifs; D, KDEX motifs; E, all other motifs found on human proteins ending L; F, other motifs found on human 
proteins ending F or M; G, linear correlation (R
2 = 0.880) between HeLa and Cos results for 27 of the KDEL variants (note the marked YCEL and 
EDEL outliers).KDEL RECEPTOR SPECIFICITIES • RAYKHEL ET AL. 1197
After optimization of the transfection and expression con-
ditions to get reproducible and reasonably uniform transfection 
with low but detectable expression levels, immunofl  uorescence 
analysis revealed that for all constructs examined, there was vari-
ability in the subcellular localization between different cells after 
transient transfection in all cell types tested, even in those tested 
at low expression levels. For all transient transfections, >80% 
of HeLa cells showed ER localization of the AKDEL-containing 
construct, with <1% of cells showing Golgi localization for any 
single transfection, and the remainder showed mixed ER–Golgi 
localization, as determined by costaining with anti-CRT and 
anti-giantin antibodies. The mixed ER–Golgi localization pos-
sibly results from saturation of the KDEL receptor system. In 
contrast, for all transfections >80% of HeLa cells transfected 
with the construct with no C-terminal retention motif showed 
Golgi localization, whereas the rest showed mixed ER–Golgi 
localization. No cells showed only ER localization of the con-
struct with no retention motif.
So that a direct comparison of the ER localization effi  -
ciency of each KDEL motif variant could be undertaken, the 
subcellular localization of each variant was examined from at 
least 150 cells in each of at least two independent experiments, 
with AKDEL-containing and no-motif controls performed in 
parallel for each set of constructs tested. In each case, abnormal-
looking cells or those undergoing nuclear division were dis-
counted from the analysis. The analysis of this set of 77 variants 
plus the no-motif control (Fig. 3, A–D) reveals that there is a 
graduation in the effi  ciency of ER localization, ranging from 
motifs that were the equivalent of AKDEL with >80% of HeLa 
cells showing ER localization, to motifs that were the equiva-
lent of the no-motif construct and >80% of HeLa cells showing 
Golgi localization. Between these two extremes there was a 
continuum of constructs that showed <80% ER localization 
and <80% Golgi localization, implying that these motifs act as 
ineffi  cient ER-localization motifs.
The results of these 77 variants also reveal that many non-
Prosite motifs are able to result in the effi  cient ER localization 
of the reporter construct. In particular, for ER localization by an 
AKDEL variant, the −4 position (i.e., the K position) is not 
limited to the six possible amino acids suggested by the Prosite 
motif (i.e., KRHSQN) but rather the aromatic amino acids F, W, 
and Y are equally as effective as K, R, H, or N and more effec-
tive than the Prosite motif options S or Q. The −3 position (i.e., 
the D position) extends far beyond the Prosite motif of E, D, Q, 
or N and includes all possible amino acids, but not the cyclic 
imino acid proline. The −2 position strongly favors E, but D 
also results in >20% of cells showing ER localization of the 
AKDDL construct. The −1 position, i.e., the L position, equally 
favors F and the Prosite motif L and to a lesser extent M, with I 
also resulting in >20% of cells showing ER localization of the 
AKDEI construct.
KDEL variants found on soluble human 
proteins
Because there are 160,000 combinations for the C-terminal four 
amino acids of a protein, a systematic examination of all pos-
sible combinations for ER localization is unfeasible. Instead, a 
bioinformatics approach was adopted to identify motifs found 
on soluble human proteins that enter the secretory pathway, i.e., 
motifs that might function in a natural system to ER localize 
human proteins. Based on the initial screen of AXDEL, AKXEL, 
AKDXL, and AKDEX variants, the bioinformatics analysis was 
restricted to human proteins that contained the motif XX[DE][FLM] 
at their extreme C terminus. Proteins containing these motifs 
were identifi  ed using Protein Prospector (Chalkley et al., 2005) 
and their sequences were analyzed by BLAST searches, Signal-P 
(Bendtsen et al., 2004), and PSORT II (Horton and Nakai, 1997) 
to confi  rm that the sequence was the full-length protein, that 
it contained an N-terminal ER signal sequence, and that it was 
not predicted to be a transmembrane protein. This analysis 
identifi  ed 113 proteins that had 63 KDEL-like variants at their 
C termini (Table S1, available at http://www.jcb.org/cgi/content/
full/jcb.200705180/DC1).
The 37 KDEL-like variants ending in L that came out of 
the bioinformatics screen and had not previously been analyzed 
were made in the reporter construct, and the subcellular local-
ization of the transiently transfected constructs was determined 
by immunofl  uorescence microscopy. The results revealed that 
15 of these motifs resulted in effi  cient ER localization (>80% 
of HeLa cells showing ER localization), whereas many others 
resulted in at least partial ER localization (Fig. 3 E). In addition, 
the effects of 10 additional variants found on human proteins 
ending in F or M were analyzed and three of these motifs re-
sulted in effi  cient ER localization (Fig. 3 F). Because two yeast 
transmembrane proteins have been reported to be localized to 
the ER by C-terminal KDEL-like motifs (Hardwick et al., 1992; 
Sweet and Pelham, 1992), eight KDEL variants, which were 
found on human transmembrane proteins whose C terminus was 
predicted to be in the ER lumen and had not been previously 
tested, were also tested, and of these, two showed effi  cient ER 
localization (Fig. S1A, available at http://www.jcb.org/cgi/content/
full/jcb.200705180/DC1). 17 other KDEL variants were also 
tested (Fig. S1 B).
Overall, the analysis of 152 different potential ER local-
ization motifs revealed that 46 were able to effi  ciently result in 
the ER localization of the reporter (>80% of cells showing only 
ER localization of the construct), whereas 60 resulted in at least 
partial ER localization and 46 were comparable to the construct 
with no motif added. Of the 46 motifs that result in effi  cient ER 
localization, 35 do not match the Prosite motif for ER localiza-
tion, whereas others that do match the Prosite motif, such as 
ASNEL, show limited ER localization or, such as ASDEL or 
AQEEL, show a signifi  cantly increased Golgi localization com-
pared with that of AKDEL.
Because Cos7 cells have been widely used to study the 
human KDEL receptors, 27 of the constructs were expressed in 
Cos7 cells and their localization was determined by immunofl  uor-
escence to look for cell type–specifi  c effects. An excellent corre-
lation was observed between the results obtained in HeLa and in 
Cos7 cells for 93% of the motifs tested (Fig. 3 G; R
2 = 0.880).
To confi  rm that the motifs resulted in ER localization or 
secretion (Golgi localization visible in cells en route to being 
secreted), the degree of secretion of 88 constructs was compared 
with that of the no-motif control. Each of these constructs was JCB • VOLUME 179 • NUMBER 6 • 2007  1198
cotransfected with the no-motif construct and 48 h after trans-
fection, the degree of secretion was examined by Western blot-
ting samples taken from cell-free media. Because the no-motif 
construct is slightly shorter than the constructs containing mo-
tifs, it migrates faster in SDS-PAGE and is thus a good internal 
control for the effects of transfection effi  ciency, expression, 
folding, and transit time through the secretory pathway. The re-
sults (Fig. S1 C) showed a good correlation with the immuno-
fl  uorescence results previously obtained but with signifi  cant 
quantitative variability between different experiments. The mo-
tif AYCEL was unusual in that it showed a reproducibly signi-
fi  cant difference, showing a high degree of ER localization by 
immunofl  uorescence in HeLa cells (Fig. 3 E) but not in Cos7 
cells (Fig. 3 G) and also a secretion effi  ciency greater than that 
of the no-motif construct by Western blot for both cell lines 
(Fig. S1 C). It was also the only motif to show a statistically sig-
nifi  cantly lower signal for interaction than the no-motif–containing 
construct with all three human KDEL receptors (for assay details, 
see Specifi  cities of the human...). These results hint at a secretion 
route for the YCEL-containing construct that does not go via the 
Golgi or transits the Golgi much faster. It may be signifi  cant that 
the three human proteins that have this motif are all associated 
with high density lipoprotein.
ER localization of human proteins
Many of the KDEL variants tested are found on human proteins 
that are annotated as being secreted or post-ER, either by elec-
tronic annotation or by using constructs in which a tag has been 
fused to the C terminus of the protein. To examine if any of these 
human proteins are ER located, 13 such proteins with non-Prosite 
motifs were cloned. All of these proteins, along with the previ-
ously cloned ERp57, ERp18, and ERp27 (Alanen et al., 2003a,b, 
2006), which also have non-Prosite motifs, were cloned with a 
tag located 5 aa before the C terminus, i.e., before the putative 
KDEL variant ER-retention motif. Transient transfection of Cos7 
or HeLa cells followed by immunofl  uorescence revealed that 
all of these proteins were located in the ER (Fig. 4 and Table I). 
Of the 14 KDEL variants used by these 16 human proteins, 9 
resulted in predominantly ER localization, 3 in predominantly 
Golgi localization (EDEL, PEGL, and QEDL), and 2 in predom-
inantly mixed ER–Golgi localization (NEDL and PDEL) of the 
reporter construct. Hence, fi  ve motifs apparently did not give 
consistent results between the natural protein and the reporter 
construct localization. However, because soluble proteins may 
be localized in the ER either by having a C-terminal KDEL-like 
motif or by interacting with a protein with such a motif, it is pos-
sible that the proteins with these fi  ve motifs may not use the mo-
tif to be ER localized, whereas we have shown (Fig. 2) that the 
reporter construct does use this motif to be ER localized.
To further examine the potential role of the C-terminal 
KDEL-like motif of each protein, a stop codon was inserted at 
the end of the tag before the putative ER-retention motif and the 
transiently transfected construct was localized by immunofl  uor-
escence. Four of the proteins with motifs that gave inconsistent 
results remained in the ER even after the motif was deleted. 
This indicates that the motif is not required for the ER localiza-
tion of these proteins. Further studies on the fi  fth motif EDEL 
revealed that for some motifs, positions −5 and −6, as well as 
the C-terminal four amino acids, play an important role in the 
effi  ciency of ER localization (unpublished data). Three of the 
16 constructs, ERp18, Hag3, and GP7R, changed their localiza-
tion from the ER to the Golgi when the putative ER-retention 
motif was not present (Fig. 4 and Table I). Furthermore, others, 
such as ERp27, showed an increased tendency to show ER–Golgi 
mixed localization when their KDEL-like motif was not present 
on the C terminus of the protein.
These results suggest that many proteins with KDEL vari-
ants at their C termini may not require them to be ER localized. 
Because this dataset was based on proteins with motifs that do 
not match the Prosite motif, we decided to also analyze a small 
set of proteins with KDEL motifs that matched the Prosite motif. 
To this end, two previously uncharacterized human proteins, along 
with the testes-specifi  c CRT3 and the peptidyl-prolyl isomerases 
FKBP7 and FKBP14, were cloned with a tag located 5 aa before 
the C terminus and with a stop codon inserted at the end of 
the tag. When transiently transfected in HeLa or Cos7 cells and 
Figure 4.  Localization of tagged human proteins with and without their 
C-terminal retention motifs. HeLa cells were transfected with the plasmid 
for ERp18–GFP–LEDEL (A), ERp18–GFP–stop (B), GP7R–HA–KKEDL (C), 
GP7R–HA–stop (D), CRT3–HA–RRNEL (E), or CRT3–HA–stop (F), ﬁ  xed, and 
stained with antibodies against CRT (A) or giantin (B) or double-stained with 
the antibodies against HA and CRT (C), HA and giantin (D), or HA and PDI 
(E and F). Merged images show good colocalization of the examined pro-
teins with ER markers (A, C, E, and F) and Golgi markers (B and D). The ex-
amples shown are of ERp18 and GP7R changing localization and CRT3 
staying in the ER after removing their putative ER-retention motif. Bars, 10 μm.KDEL RECEPTOR SPECIFICITIES • RAYKHEL ET AL. 1199
visualized by immunofl  uorescence, all fi  ve proteins were located 
in the ER and all remained localized to the ER upon deletion 
of the KDEL-like motif (Table I), presumably because of their 
interaction with other proteins with KDEL-like motifs.
Speciﬁ  cities of the human KDEL receptors
With three different human KDEL receptors present in the same 
cell and showing widespread tissue distribution, the possibility 
arises that each receptor acts to retrieve different subgroups of 
proteins based on the KDEL variant they have at their C terminus. 
To test this hypothesis, a BiFC assay was established. Similar 
constructs to those used to study the interaction of ERp57 and 
ERp27 (Alanen et al., 2006) were made with parts of YFP fused 
to human ERD21, 22, and 23 and variants of the reporter with 
either AKDEL or no retention motif at the C terminus (Fig. 5 A).
Upon expression in HeLa cells, negligible fl  uorescence 
was observed by fl  ow cytometry with the ER-targeted YFP 
fragments Y1 alone or Y2 alone. Expression of any combina-
tion of Y1- and Y2-tagged constructs in the same subcellular 
compartment results in an increase in fl  uorescence because of 
nonspecifi  c interactions. Hence, coexpression of the Y1-tagged 
KDEL receptors with the Y2-tagged variant of the reporter, 
which contained no retention motif, or the coexpression of Y1 
and Y2   resulted in a small increase in fl  uorescence. However, a 
signifi  cantly greater fl  uorescence was observed when any of the 
Y1 fragment–tagged KDEL receptors were coexpressed with 
the Y2 fragment–tagged AKDEL variant of the reporter con-
struct (Fig. 5 B). This implies that there are specifi  c interactions 
between the three KDEL receptors and the KDEL motif that 
can be detected by an increase in the BiFC fl  uorescence signal 
intensity. The signal obtained with ERD21 was significantly 
greater than that obtained with ERD23, which in turn was sig-
nifi  cantly greater than that obtained by ERD22, suggesting that 
ERD22 and 23 may favor interaction with motif variants other 
than KDEL.
Because statistically signifi  cantly (P < 0.01) larger sig-
nals were observed by BiFC in the BiFC fl  uorescence intensities 
for all three human KDEL receptors interacting with the AKDEL-
containing reporter compared with the no-motif–containing 
  reporter, 84 other KDEL-like variants were cloned into the 
BiFC system and their interactions with the three human KDEL 
receptors analyzed. The results showed a continuum of intensity 
signals ranging from signals comparable to that obtained with 
the no-motif construct up to, and beyond, the signal obtained 
with the KDEL motif. This continuum is consistent with the re-
sults obtained by immunofl  uorescence analysis of ER localiza-
tion effi  ciency, which showed that as well as effi  cient motifs and 
motifs that had no effect on ER localization, there were also a 
wide range of weak localization motifs.
Overall, there was a very good correlation between the 
magnitude of the BiFC fl  uorescence signal obtained and degree of 
ER localization previously determined by immunofl  uorescence 
(Table S2, available at http://www.jcb.org/cgi/content/full/jcb
.200705180/DC1), especially for ERD21 and 23 (Fig. 5 C).This 
is consistent with the direct role of these receptors in mediating 
ER localization. However, there were clear differences between 
the three KDEL receptors. 43 of the AXXXX KDEL-like motifs 
tested had previously been shown to be effi  cient signals for ER 
localization (>80% of cells showing only ER localization; Fig. 3). 
All of these motifs showed a statistically signifi  cantly higher 
signal (P < 0.01) than the no-motif construct for interaction 
with ERD21, whereas only 41 of the 43 motifs showed the same 
correlation for ERD23. In contrast, 18 of the 43 motifs did not 
show a statistically signifi  cantly higher (P < 0.01) BiFC signal 
than the no-motif construct for ERD22. Indeed many motifs, 
including KAEL, NDEL, and REDL, which are found on soluble 
Table I. Localization of tagged human proteins, both with a C-terminal KDEL-like motif and with this motif deleted by the addition of a stop codon
Motif Swiss-Prot ID Gene name Protein name Tag Localization Localization with stop
EDEL O95881 TXNDC12 ERp18 GFP ER Golgi
HDEL Q9Y680 FKBP7 FKBP7 HA ER ER
Q9NWM8 FKBP14 FKBP14 HA ER ER
HEEL Q8WUF8 C5orf21 C5orf21 HA ER ER
KAEL Q8IXL7 MSRB3 MSRB3 HA ER ER
KDEF Q9UMX5 NENF Neudesin HA ER ER
KEDL Q8TED1 LOC493869 FLJ23636 HA ER ER
KEEL Q8IWF2 FOXRED2 FOXRED2 HA ER ER
KTEL O95994 AGR2 Hag-2 Myc ER ER
Q9UHG3 PCYOX1 Prenylcysteine oxidase HA ER ER
Q8N2T1 KTELC1 CLP46 HA ER ER
KVEL Q96DN0 ERP27 ERp27 Myc ER ER
NEDL Q8WXA2 PATE PATE Myc/HA ER ER
PDEL Q9BT09 TNRC5 TNRC5 HA ER ER
PGEL Q8NBJ7 SUMF2 pFGE Myc/HA ER ER
QEDL P30101 PDIA3 ERp57 GFP ER ER
QSEL Q8TD06 AGR3 hAG-3 Myc ER Golgi
REDL Q96SL4 GPX7 Glutathione peroxidase 7 HA ER Golgi
RNEL Q96L12 CRT3 CRT3 HA ER ER
RTDL P55145 ARMET ARMET Myc ER ER
RTEL P26885 FKBP2 FKBP2 HA ER ERJCB • VOLUME 179 • NUMBER 6 • 2007  1200
human proteins that enter the secretory pathway, showed a signal 
that was statistically indistinguishable from that of the no-motif 
construct. Hence, ERD22 appears to be a specialist.
More detailed examination of the BiFC results from the 
85 KDEL variant constructs showed very clear differences in the 
specifi  cities of the three human KDEL receptors. ERD21 appears 
to be a generalist (Fig. 5 D for motifs found on human proteins 
and Table S2), with AHAEL, AHDEF, AHEEF, AHEEL, AHDEF, 
AHTEL, ARDEL, and AREEL showing no signifi  cant differ-
ence in signal compared with AKDEL (at 5% signifi  cance level) 
and 63 out of 85 motifs showing a signifi  cantly larger   signal 
(P < 0.05) than the no-retention–motif construct, including all 
KXEL variants.
In contrast to ERD21, ERD22 does not favor KDEL or 
closely related motifs and it appears to be more specialized 
(Fig. 5 E for motifs found on human proteins and Table S2). 
Although ERD22 gives only a weak signal when coexpressed 
with the AKDEL-retention motif, it gives signifi  cantly stronger 
signals with motifs of the sequence HXEL.
ERD23, like ERD21, appears to be a generalist (Fig. 5 F 
for motifs found on human proteins and Table S2), giving a sta-
tistically signifi  cant signal (P < 0.01) with 41 motifs versus 43 
motifs for ERD21. Closer examination of the data, however, 
reveals several subtle differences in the specifi  cities of the two 
receptors. Furthermore, there is one very clear difference. Although 
ERD21 favors KDEL over HDEL (P < 0.01), ERD23 favors 
Figure 5.  Analysis of the speciﬁ  city of the three human KDEL receptors. (A) Schematic of the constructs used. (B) Proof of concept. For each of the three 
KDEL receptors the BiFC ﬂ  uorescence signal counted from 3,000 cotransfected HeLa cells was signiﬁ  cantly higher for the interaction with the KDEL-contain-
ing reporter than for the no-motif–containing reporter. The data represents the mean and standard deviation from four to six replicates. (C) Correlation be-
tween the ER localization of 85 of the KDEL variant reporter constructs and the mean BiFC signal for interactions with ERD21 and 23. A horizontal line is 
drawn at 80% ER localization (representing our deﬁ  nition of an efﬁ  cient ER-localization motif) and a vertical line is drawn at 30% of the mean BiFC signal 
obtained with KDEL. Note the absence of motifs in the bottom right and the small number of motifs in the top left. (D–F) The BiFC measurements for each hu-
man KDEL receptor interacting with KDEL variants found on human proteins that result in efﬁ  cient ER localization by immunoﬂ  uorescence. The BiFC measure-
ments are normalized to KDEL as 100% (dotted lines) and no motif as 0%. D, ERD21; E, ERD22; F, ERD23. The data represents the mean and standard 
deviation from six replicates.KDEL RECEPTOR SPECIFICITIES • RAYKHEL ET AL. 1201
HDEL very markedly over KDEL (P < 0.01). Because KDEL 
and HDEL are the most common ER-retrieval motifs found on 
human proteins (Table S1), this marked difference is probably 
physiologically signifi  cant.
In addition to allowing quantifi  cation of the relative effi  -
ciency of interaction, BiFC also allows the steady-state local-
ization of the complex. For all combinations tested of the three 
receptors with motifs that gave a strong BiFC signal, the fl  uor-
escence observed by fl  uorescence microscopy showed a punc-
tate distribution consistent with potential vesicular localization 
(Fig. 6 A). Costaining with an antibody against β-COP revealed 
considerable overlap between the BiFC signal and COP-I local-
ization. This result is consistent with a functional interaction 
between the receptor and the motif resulting in recycling of the 
complex back to the ER. However, because of BiFC complex 
formation, the complex of the receptor and KDEL motif re-
porter is unable to dissociate in the ER, which leads to constant 
recycling. In contrast to this result, BiFC localization of all three 
receptors with the no-motif reporter showed a weaker, more dif-
fuse fl  uorescence signal, which colocalized with the signal from 
an anti-giantin antibody (Fig. 6 B). This result is consistent with 
a nonfunctional nonspecifi  c association between the receptor 
and the reporter construct.
Discussion
Compartmentalization is essential for cellular function. It is 
  especially relevant for soluble proteins with an N-terminal signal 
sequence that targets them to the ER. Such proteins are secreted 
when correctly folded unless there is active partitioning to the 
correct subcellular compartment. This partitioning requires a 
motif to signal to the appropriate machinery that this protein 
should be located in the ER, Golgi, lysosome, etc. The initial 
work on ER localization for soluble proteins in Saccharomyces 
cerevisiae (Pelham et al., 1988; Lewis et al., 1990; Semenza et al., 
1990) identifi  ed a C-terminal motif, HDEL, which interacted 
with a Golgi-located HDEL receptor, an interaction that resulted 
in the retrieval of the complex to the ER. Subsequently, the fi  rst 
human KDEL receptor was identifi  ed (Lewis and Pelham, 1990) 
followed by the second (Lewis and Pelham, 1992a). Although 
some work was reported toward the specifi  city of the KDEL re-
ceptor (Semenza and Pelham, 1992), there is a noticeable ab-
sence of discussion as to why mammals require two receptors to 
perform an identical function. This question became more per-
tinent with the appearance in the databases of a third human KDEL 
receptor. To our knowledge, this is the fi  rst paper regarding 
the localization or functional characterization of this receptor. 
In addition, here, we demonstrate that the Prosite motif for ER 
localization needs revision. Of the 152 different potential reten-
tion motifs tested, 46 resulted in effi  cient ER retention with 35 
of these not matching the Prosite motif. Furthermore, several 
motifs that did match the Prosite motif did not result in effi  cient 
ER localization. The motifs that result in effi  cient ER localiza-
tion are found on 70 human proteins, many of which are of cur-
rently unknown or poorly defi  ned function.
With three distinct KDEL receptors in mammals showing 
 20% difference in amino acid sequence, there may be some 
difference in function. Because all three receptors are widely 
expressed in a range of human tissues and are expressed at the 
same time in a human cell line, the most likely functional differ-
ence would be differences in substrate specifi  city. Here, we show 
for the fi  rst time the specifi  city of a KDEL receptor.   Furthermore, 
we show that the three human KDEL receptors ERD21, 22, and 
23 have different specifi  cities, with ERD21 and 23 being gener-
alists and ERD22 being a specialist.
There are three generally recognized methods for ER lo-
calization of folded soluble proteins: via the KDEL receptors, 
by noncovalent interactions with proteins that are retained by 
the KDEL receptors, e.g., the P4H α-subunit is retained by PDI 
(Vuori et al., 1992), or by thiol-mediated retention, e.g., ERo1α 
by ERp44 (Anelli et al., 2002). The excellent correlation between 
immunofl  uorescence-based localization and the interactions of 
the constructs with the human KDEL receptors (Fig. 5 C and 
Table S2) implies that, for the 152 variants of the reporter tested, 
ER localization is mediated only via the KDEL receptors. There 
is no evidence from our data for a general thiol-based retention 
Figure 6.  Subcellular localization of BiFC interactions. HeLa cells were cotransfected with the plasmid for the Y1 fragment–tagged ERD21 (A and B) and 
the Y2 fragment–tagged AKDEL variant of the reporter construct (A) and the Y2 fragment–tagged no-motif reporter construct (B), ﬁ  xed, and stained with anti-
bodies against β-COP (A) or giantin (B). Merged images show good colocalization of the interacted proteins with the COP-I marker (A) and Golgi marker 
(B), respectively. The inset in A shows a closeup of the boxed area. Bars, 10 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1202
mechanism for folded proteins because constructs with the motifs 
ACSDL, ACTDL, AKDCL, and AKDEC are secreted, whereas 
CDEL and KCEL, which are retained, interact with the KDEL 
receptors (Fig. 3 and Table S2). In contrast, there is indirect evi-
dence for large-scale retention via noncovalent complex forma-
tion. Some complexes have previously been reported (Meunier 
et al., 2002). Here, we report that deleting the KDEL-like motif 
from 21 ER-localized human proteins resulted in the secretion 
of only three of them (Table I). Although some of the others are 
known to form complexes, e.g., ERp57 with CRT, calnexin, or 
ERp27 (Oliver et al., 1997; Zapun et al., 1998; Alanen et al., 2006), 
the rest are generally not well characterized, but complex forma-
tion can be hypothesized. In a separate incomplete large-scale 
screen for interactions in the ER, all 18 proteins that do not change 
localization upon removal of the C-terminal motif were found to 
interact with at least one other ER-resident protein with a KDEL-
like motif (unpublished data).
In addition to soluble proteins, it has been previously re-
ported that two yeast transmembrane proteins are retained in 
the ER by a luminal C-terminal HDEL motif (Hardwick et al., 
1992; Sweet and Pelham, 1992). Here, we fi  nd that four human 
transmembrane proteins have C-terminal KDEL variants (Fig. 
S1 A and Table S3, available at http://www.jcb.org/cgi/content/
full/jcb.200705180/DC1) that act as effi  cient ER localization 
motifs and that three of these four motifs are conserved between 
human and mouse, which implies functionality. Because trans-
membrane proteins were not the focus of our bioinformatics 
search, it is possible that there are many more yet to be iden-
tifi  ed. This question needs addressing: why use these motifs 
rather than the widely used cytoplasmic C-terminal KKXX or 
RXR motifs?
What is the functional signifi  cance of the three KDEL re-
ceptors having different specifi  cities? This question is not easy 
to answer because the three receptors have overlapping speci-
fi  cities and because RNAi studies are not viable without recep-
tor-specifi  c antibodies. An analysis based on the function of the 
proteins with motifs that are recognized by the different recep-
tors is also diffi  cult because for many of these proteins either 
the function is poorly understood or they belong to a family of 
proteins with a known function but where the exact physiologi-
cal role of each of the multiple family members in the ER is un-
clear. However, some generalizations can be made. All of the 
carboxylesterases with KDEL-like motifs have a motif that is 
recognized by ERD22 better than KDEL is. Other proteins with 
motifs recognized by ERD22 include proteins, such as sulfami-
dase, which are thought to be located in other subcellular com-
partments (for review see Anson and Bielicki, 1999). ERD21, in 
contrast, recognizes motifs that are found on all of the molecular 
chaperones and protein-folding catalysts that have been reported 
to interact early with nascent protein chains entering the ER. 
These results suggest that the exact KDEL-like motif a protein 
has may be of functional important, i.e., that KDEL, a strong 
ERD21 interaction motif, is not the same as HVEL, a strong 
ERD22 motif, or HDEL, a strong ERD23 motif.
Because the KDEL receptors are very similar between 
human and mouse, showing 99.5, 98.6, and 92.5% identity for 
ERD21, 22, and 23, respectively, further evidence for the poten-
tial importance of the specifi  city of the KDEL-like motif used 
by a single protein can be found from a cross-comparison be-
tween human and mouse proteins. BLAST searches using the 
sequences of the 116 human proteins previously identifi  ed to be 
soluble proteins that entered the secretory pathway (Table S1) 
allowed for the identifi  cation (including the C-terminal motif) 
of 111 homologous mouse proteins. For this dataset, the mean 
percentage identity between the human and mouse proteins 
is 86.0%, which implies that for any four-amino stretch, the 
expected chance that all four amino acids are identical would 
be 0.86
4, or  55%. For those regions that are functional, e.g., 
active sites, this probability would be expected to be higher, 
whereas for nonfunctional regions this probability would be ex-
pected to be lower. For the 42 proteins with motifs that did not 
act as an effi  cient ER-localization motif in the immunofl  uores-
cence-based reporter assay system and for which a mouse ho-
mologue was identifi  ed, 21 proteins (50% of the total) showed 
conservation of the KDEL-like motif between mouse and human 
proteins. This result, 50 versus 55% random chance, suggests 
that the KDEL-like motifs at the C terminus of these proteins 
were nonfunctional, which is in line with the results from the 
reporter assay system. In contrast to the 69 proteins with KDEL-
like motifs that were effi  cient in ER localization of the reporter 
and for which a mouse homologue was identifi  ed, 58 (84% of 
the total) showed conservation of the KDEL-like motif between 
the human and mouse proteins, whereas a further 5 (7%) had a 
very similar motif that would be recognized by the same KDEL 
receptor. Of the remaining six proteins, two, ERp27 and CALR3, 
formed part of the protein screen for ER localization reported 
here, and although both were ER located, when the KDEL-like 
motif was deleted they remained in the ER, indicating that the 
KDEL-like motif was not the primary affecter of ER localiza-
tion for these proteins. These results, 84 + 7% versus 55% ran-
dom chance, strongly suggest that the KDEL-like motif at the 
C terminus of this grouping of proteins is functional and that it 
is important which KDEL-like motif a protein has or at least 
that it is a motif that is recognized by the same receptor. A similar 
analysis across different species grows increasingly compli-
cated, not only because of the positive identifi  cation of the KDEL 
motif–containing proteins, especially because many ER pro-
teins exist in families, e.g., there are at least 17 human PDI fam-
ily members (Ellgaard and Ruddock, 2005), but also because 
of the growing dissimilarity of the KDEL receptors between 
species. However, as a generalization, KDEL-like motifs are 
conserved between human and the African clawed frog (Xenopus 
laevis; 24/29 or 83% of proteins would use the same human 
  receptor most effi  ciently), which also has three KDEL receptors, 
whereas yeast (S. cerevisiae), which has only one KDEL receptor, 
exclusively uses HDEL, and fruitfl  ies (Drosophila melanogaster), 
which also have only one KDEL receptor, show a greatly increased 
propensity to use motifs commencing with histidine.
Although there are still many unanswered questions, such 
as what determines the specifi  cities of the three receptors and 
their interactions with vesicular transport proteins, this study, 
by determining that the three human KDEL receptors have dif-
ferent specifi  cities, opens up new possibilities for the subcompart-
mentalization of the secretory pathway.KDEL RECEPTOR SPECIFICITIES • RAYKHEL ET AL. 1203
Materials and methods
Plasmid construction
Plasmids encoding for ERp18 (including GFP tagged), ERp27 (including myc 
tagged), ERp57, and PDI were generated previously (Alanen et al., 2003b, 
2006). The following plasmids encoding for full-length human proteins 
were generated by cloning PCR products from IMAGE clones into pET23 
(EMD): ERD21 (5214794), ERD22 (5183647), ERD23 (3462392), FKBP7 
(3891173), FKBP14 (4042173), C5orf21 (4398813), MSR3B (6025598), 
NENF (1895972), LOC493869 (7472098), FOXRED2 (3873448), AGR2 
(3852448), PCYOX1 (5207140), KTELC1 (4796951), PATE (5745088), 
TNRC5 (2959532), SUMF2 (6599080), AGR3 (4694757), GPX7 (3628580), 
CRT3 (4822010), ARMET (3354774), and FKBP2 (3049222). These plas-
mids were then used as templates to generate tagged proteins by PCR in 
mammalian expression vectors (for a list of constructs see Table S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705180/DC1).
The control plasmid for real-time PCR analysis of ERD22 mRNA levels, 
whose sequence, including part of the noncoding region of the mRNA, 
was cloned using the primers 22 forward and 22 reverse (see below) in 
pcDNA3.1 using total RNA from HeLa cells as the template. The control 
plasmid for real-time PCR analysis of ERD23 isoform 2 was cloned using 
annealed synthetic complementary primers into pJKJ18.
The reporter construct (see Fig. 2 A for a schematic) was constructed 
with and without a C-terminal AKDEL motif by cloning the b domain of PDI 
by PCR in frame into a pET23 vector, to which the signal sequence of CRT 
and a HA tag had already been added using annealed synthetic comple-
mentary primers.
BiFC vectors targeted to the ER were made previously (Alanen et al., 
2006) according to the design of Nyfeler et al. (2005), with the Q69M 
mutation introduced into the Y1 fragment to reduce environmental sensitivity 
of ﬂ  uorescence (Griesbeck et al., 2001). Constructs expressing ERD21, 
22, and 23 and 86 KDEL variants of the reporter construct were subcloned 
into these vectors (see Fig. 5 A for schematic).
Point mutations in plasmids were performed as recommended by the 
manufacturer using the QuikChange kit (Stratagene). All 486 generated plas-
mids were sequenced to ensure that there were no errors in the cloned genes.
Cell transfections
HeLa (American Type Culture Collection CCL2) or Cos7 cells (American 
Type Culture Collection) were grown on 6-well plates with or without glass 
coverslips in DME-high glucose medium supplemented with Glutamax 
  (Invitrogen), 10% FCS (Sigma-Aldrich), 100 U/ml penicillin, and 100 μg/ml 
streptomycin (100× penicillin-streptomycin solution; Sigma-Aldrich). Cells 
seeded one day earlier were transfected according to the manufacturer’s 
protocol with 3 μl of Fugene6 transfection reagent (Roche) and 0.1–1 μg 
of plasmids. After extensive optimization, 0.3 μg of reporter construct 
plasmid of 0.5 μg of human KDEL receptor was used for all transfections 
reported. For each transfection, KDEL and no-motif controls were performed. 
Cells showing abnormal cell morphology or undergoing nuclear division 
were not included in the analysis. The cotransfection efﬁ  ciency was 40–55% 
and control experiments with ERD21/22/23-Myc and the HA-tagged reporter 
construct with AKDEL showed that only  1% of cells showed a single with 
either only Myc or only HA.
Immunoﬂ  uorescence
After 24 to 48 h, the transfected cells were rinsed with PBS, ﬁ  xed with 4% 
paraformaldehyde for 30 min at RT, and processed for indirect immuno-
ﬂ   uorescence as described previously (Alanen et al., 2006) using Immu-
Mount medium (Thermo Fisher Scientiﬁ  c). The following antibodies were 
used: monoclonal antibody against PDI (Dako), polyclonal antibody against 
CRT (Afﬁ  nity BioReagents), polyclonal antibody against giantin (Abcam), 
  polyclonal antibody against β-COP (Afﬁ  nity BioReagents), C-Myc mono-
clonal (Santa Cruz Biotechnology, Inc.) and polyclonal (Abcam) anti  bodies, 
and HA monoclonal (Sigma-Aldrich) and polyclonal (Abcam) anti  bodies. 
The Alexa Fluor 488 (ab′)2 fragment of goat anti–mouse IgG (Invitrogen) 
and Alexa Fluor 594 (ab′)2 fragment of goat anti–rabbit IgG (Invitrogen) 
were used as secondary antibodies. Fixed and stained cells were examined 
with an epiﬂ  uorescence microscope (BX61; Olympus) ﬁ  tted with oil immersion 
objectives (100×/1.35 NA). Images were recorded with a charge-coupled 
device camera (Soft Imaging System) controlled by Analysis software (Soft 
Imaging System), converted to TIFF ﬁ  les, adjusted for brightness and contrast, 
and assembled into montages with Photoshop 8.0 (Adobe).
BiFC measurements
For ﬂ  ow cytometric analysis, HeLa cells were grown on 24-well plates. 
  After extensive optimization, 0.2 μg/well of each plasmid and 1.5 ml of 
Fugene6 transfection reagent were used. Furthermore, because the Y1-KDEL 
receptor–Y2-reporter construct gave larger and more reproducible ﬂ  uores-
cence signals than the Y2-KDEL receptor–Y1-reporter construct combina-
tion, it was used for all of the transfections reported here. After 24 h, the 
cells were rinsed with PBS and then detached from the plate by incubating 
them with 500 μl Trypsin-EDTA solution (0.5 mg/ml Trypsin and 0.02% 
EDTA in PBS) for 5 min at 37°C. The cells were then collected by centrifuga-
tion at 400 g for 5 min at 4°C and resuspended in 1 ml PBS containing 2% 
FCS. For each sample, the yellow ﬂ  uorescence of 3,000 cells was then an-
alyzed using a CyFlow ﬂ  ow cytometer (Partec) with appropriate ﬁ  lter sets. 
Gating to analyze the mean ﬂ  uorescence intensity of transfected cells was 
performed using FloMax software (Partec). On all days on which samples 
were analyzed, controls with the appropriate Y1-KDEL receptor–Y2-reporter 
construct with AKDEL and the Y1–Y2 control were performed at least in 
duplicate along with a nontransfected control. Transformation with the con-
trol Y1–ERD21 or Y2 reporter constructs resulted in transfected cells whose 
ﬂ  uorescence intensity overlapped with that of the nontransfected cell popu-
lation, and therefore the mean ﬂ  uorescence intensity of these controls 
could not be determined accurately, although it was <1% of that of the 
Y1-ERD21 + Y2 reporter construct with AKDEL sample.
RT-PCR
RT-PCR was performed using the AccessQuick RT-PCR system (Promega) 
according to the manufacturer’s protocol, using total RNA isolated from 
nontransfected HeLa cells using the E.Z.N.A Total RNA kit (Omega Bio-Tek) 
according to the manufacturer’s protocol. The following primers were used 
for RT-PCR to show the presence of mRNA in nontransfected cells: ERD21, 
forward, C  A  C  A  G  C  C  A  T  T  C  T  G  G  C  G  T  T  C  C  T  G  , and reverse, C  G  T  G  C  G  G  T  A  A-
A  C  G  C  C  T  A  G  C  G  C  ; ERD22, forward, G  G  G  C  T  T  C  T  T  T  G  A  C  C  T  C  A  T  T  G  , and 
reverse, T  G  C  C  T  T  T  G  C  T  G  T  G  G  T  A  A  G  A  A  ; ERD23.1, forward, G  T  T  T  T  T  C  T  C-
C  T  C  T  G  T  G  C  C  T  A  T  G  T  T  , and reverse, A  G  C  C  A  G  G  T  A  G  A  G  T  G  C  C  C  G  G  T  A  C  ; 
and ERD23.2, forward, G  T  T  T  T  T  C  T  C  C  T  C  T  G  T  G  C  C  T  A  T  G  T  T  , and reverse, 
C  C  T    T  A  G  G  C  C  A  G  T  G  T  C  A  G  C  A  T  T  G  C  T  G  T  C  A  T  C  C  C  .
Real-time quantitative PCR
For real-time quantitative PCR analysis of the genes encoding for ERD21, 
22, and 23, cDNA was produced using the First Strand cDNA Synthesis 
kit (MBI Fermentas) using total RNA isolated from HeLa cells with RNeasy 
Mini kit (QIAGEN). Control plasmids pJKJ22, pIBR25, pJKJ18, and pIBR26 
(Table S4) were used. Real-time quantitative PCR was performed using a 
7500 Real Time PCR System (Applied Biosystems) using the primers listed 
in the RT-PCR section and Power SYBR Green PCR Master Mix (Applied 
Biosystems) according to the manufacturer’s instructions. For the relative 
quantiﬁ  cation of mRNA, the results were analyzed with 7500 System Soft-
ware (Applied Biosystems).
Online supplemental material
Table S1 is a list of human gene products, and their Swiss-Prot identiﬁ  cation 
numbers, that are predicted to enter the secretory pathway and to have no 
predicted transmembrane regions and which have a motif XX[DE][FLM] at the 
C terminus. Table S2 represents correlations between immunoﬂ  uorescence 
localization of the reporter constructs and the BiFC ﬂ  uorescence  signal 
for interactions with the three human KDEL receptors. Table S3 is a list of 
human gene products, and their Swiss-Prot identiﬁ  cation numbers, that are 
  predicted to enter the secretory pathway and have a predicted transmem-
brane region and a motif XX[DE][FLM] at the C terminus. Table S4 is a list of 
constructs used. Fig. S1 shows immunoﬂ  uorescence and Western blot–based 
localization of the reporter constructs. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705180/DC1.
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